Literature DB >> 3928537

Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype.

G C Manara, G De Panfilis, C Ferrari, A Bonati, G Rocchi, R Scandroglio.   

Abstract

The ultrastructural features of the Leu-7-positive - Leu-M3-positive cell subpopulation and the Leu-7-positive - Leu-4-positive cell subpopulation were characterized and compared using immunogold-immunoperoxidase double labelling with immunoelectron microscopy. The majority of Leu-7-positive cells coexpressed a monocyte phenotype and showed an ultrastructural pattern specific for functional natural killer (NK) cells, i.e. a low nuclear/cytoplasmic (N/C) ratio, an irregular outline, many cytoplasmic organelles and electron-dense granules. In contrast, only a minority of Leu-7-positive cells coexpressed a T phenotype, and these were characterized by a high N/C ratio, an even surface and the absence of electron-dense granules. Thus, Leu-7-positive - Leu-4-positive cells may by an immature form of NK cells, and Leu-7-positive - Leu-4-positive and Leu-7-positive - Leu-M3-positive cell subpopulations may represent different stages of Leu-7-positive cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928537     DOI: 10.1007/bf00489973

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  16 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis.

Authors:  C Dezutter-Dambuyant; G Cordier; D Schmitt; M Faure; C Laquoi; J Thivolet
Journal:  Br J Dermatol       Date:  1984-07       Impact factor: 9.302

3.  Quantitative analysis of cell surface HLA structures by means of monoclonal antibodies.

Authors:  M Trucco; S de Petris; G Garotta; R Ceppellini
Journal:  Hum Immunol       Date:  1980-10       Impact factor: 2.850

Review 4.  Human NK cells: light and electron microscopic characteristics.

Authors:  G F Babcock; J H Phillips
Journal:  Surv Immunol Res       Date:  1983

5.  Ultrastructural, immunocytochemical localization of presumptive erythropoietin binding sites on developing erythrocytic cells of normal human bone marrow.

Authors:  M D Lafferty; G A Ackerman; C D Dunn; R D Lange
Journal:  J Histochem Cytochem       Date:  1981-01       Impact factor: 2.479

6.  The fine structure of HNK-1 (Leu7) positive cells. A study using an immunoperoxidase technique.

Authors:  G C Manara; G de Panfilis; C Ferrari; A Bonati; R Scandroglio
Journal:  Histochemistry       Date:  1984

7.  Large granular lymphocytes: morphological studies.

Authors:  D Huhn; C Huber; G Gastl
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

8.  Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression.

Authors:  L L Lanier; M R Loken
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  In vitro propagation of cultured human natural killer cells expressing the HNK-1 differentiation antigen and spontaneous cytotoxic function.

Authors:  T Abo; C M Balch
Journal:  Eur J Immunol       Date:  1983-05       Impact factor: 5.532

10.  Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.

Authors:  T Abo; C A Miller; G L Gartland; C M Balch
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  1 in total

1.  Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency.

Authors:  S Takagi; J Minakuchi; H Okawa; J Yata
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.